GLP-1 Weight Maintenance Study
If you would like to learn more or are interested in participating, please email us at niche@utsouthwestern.edu or complete the eligibility screener under the description.
Have you recently stopped taking a GLP-1 medication, but worry about weight regain?
You may be eligible to participate in this study to see if there are ways to help people maintain weight loss after stopping a GLP-1. This study aims to test whether two alternative strategies, medically tailored meals and/or digital behavioral strategies, such as the Noom® app can help patients maintain weight loss and protect against weight regain for those who have to or want to stop taking GLP-1 RA's.
​
Who is eligible? Adult 18+, greater than 10% weight loss from taking GLP-1 RA medications (e.g., Trulicity, Bydureon bcise, Byetta, Ozempic, Victoza,Saxenda, Adlyxin, Rybelsus, etc.), less than 30 days since stopping medication.
​
What does it entail? Random assignment to one of three groups that receive usual care, a Noom® subscription, or medically tailored meals. Month 1: Remote weigh-in and questionnaire completed by phone or online, Month 2 & 3: Remote weigh-in, Month 4: Remote weigh-in & second questionnaire. Participants are paid up to $40 & receive a free bluetooth scale.
​
​How do I sign up? Email, call, or text us if you'd like to participate or complete the eligibility screener by clicking here: https://redcap.link/5r9nwqej
​
Collaborators: Ildiko Lingvay, MD, MPH, MSCS
